CENTRAL LIBRARY

Welcome to Online Public Access Catalogue (OPAC)

Amazon cover image
Image from Amazon.com

Advances in combination therapy for asthma and COPD / editor, Jan Lötvall.

Contributor(s): Material type: TextTextPublication details: Chichester, West Sussex : John Wiley & Sons, 2012.Description: 1 online resource (xii, 350 pages) : illustrationsContent type:
  • text
Media type:
  • computer
Carrier type:
  • online resource
ISBN:
  • 9781119998631
  • 1119998638
  • 9781119998624
  • 111999862X
  • 9781119978466
  • 1119978467
  • 0470727020
  • 9780470727027
Subject(s): Genre/Form: Additional physical formats: Print version:: Advances in combination therapy for asthma and COPD.DDC classification:
  • 616.2/3061 23
LOC classification:
  • RC776.O3 A33 2012eb
NLM classification:
  • WF 553
Online resources:
Contents:
Similarities and differences in the pathophysiology of asthma and COPD / Christian Virchow -- Glucocorticoids : pharmacology and mechanisms / Peter Barnes -- Inhaled corticosteroids? clinical effects in asthma and COPD / Paul O'Byrne -- LABAS : pharmacology, mechanisms and interaction with anti-inflammatory treatments / Gary Anderson -- Long and ultra-long acting beta-2-agonists / Mario Cazzola -- The safety of long-acting beta agonists and the development of combination therapies for asthma and chronic obstructive pulmonary disease / Eugene Bleecker -- Inhaled combination therapy with glucocorticoids and long-acting beta-2-agonists in asthma and COPD, current and future perspectives / Jan Lotvall -- Novel anti-inflammatory treatments for asthma and COPD / Ian Adcock -- Novel biologicals alone and in combination in asthma and allergy / William Busse -- Anti-infective treatments in asthma and COPD / Jonathan D.R. Macintyre & Sebastian L. Johnston -- Long acting muscarinic antagonists in asthma and COPD / Denis O'Donnell -- Phosphodiesterase inhibitors in obstructive lung disease / Jan Lotvall -- Biological therapies in development for COPD / Riccardo Polosa -- Triple therapy?, in the management of chronic obstructive lung disease (COPD). The value of combination treatment with inhaled steroid, long acting anticholinergicbronchodilator and long acting beta 2 agonist bronchodilator in COPD / Ronald Dahl.
Tags from this library: No tags from this library for this title. Log in to add tags.
No physical items for this record

Includes bibliographical references and index.

Similarities and differences in the pathophysiology of asthma and COPD / Christian Virchow -- Glucocorticoids : pharmacology and mechanisms / Peter Barnes -- Inhaled corticosteroids? clinical effects in asthma and COPD / Paul O'Byrne -- LABAS : pharmacology, mechanisms and interaction with anti-inflammatory treatments / Gary Anderson -- Long and ultra-long acting beta-2-agonists / Mario Cazzola -- The safety of long-acting beta agonists and the development of combination therapies for asthma and chronic obstructive pulmonary disease / Eugene Bleecker -- Inhaled combination therapy with glucocorticoids and long-acting beta-2-agonists in asthma and COPD, current and future perspectives / Jan Lotvall -- Novel anti-inflammatory treatments for asthma and COPD / Ian Adcock -- Novel biologicals alone and in combination in asthma and allergy / William Busse -- Anti-infective treatments in asthma and COPD / Jonathan D.R. Macintyre & Sebastian L. Johnston -- Long acting muscarinic antagonists in asthma and COPD / Denis O'Donnell -- Phosphodiesterase inhibitors in obstructive lung disease / Jan Lotvall -- Biological therapies in development for COPD / Riccardo Polosa -- Triple therapy?, in the management of chronic obstructive lung disease (COPD). The value of combination treatment with inhaled steroid, long acting anticholinergicbronchodilator and long acting beta 2 agonist bronchodilator in COPD / Ronald Dahl.

Print version record.

There are no comments on this title.

to post a comment.

Khulna University of Engineering & Technology

Funded by: HEQEP, UGC, Bangladesh